23andMe gets FDA clearance for prostate cancer risk test
Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test, the company announced today. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk.
23andMe Initiates Phase 1 Clinical Trial for First Wholly-Owned Immuno-oncology Antibody for Patients with Solid Tumors
23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced the first participant has been dosed in a Phase 1 clinical trial evaluating 23ME-00610 for the treatment of advanced solid tumors.
DAILYPAY ANNOUNCES ITS DIGITAL WALLET SOLUTION TO HELP WORKERS STAY FINANCIALLY STABLE
DailyPay, featured in TIME’s “Best Inventions of 2021,” today announced their one-of-a-kind digital wallet solution. DailyPay’s digital wallet solution is designed for everyday working Americans, many of whom are facing unprecedented financial challenges with the resurgence of the pandemic.
HealthCare.com® Raises $180 Million in Oversubscribed Financing Round Led by Oaktree
HealthCare.com, a leading data-driven insurtech platform, announced today the closing of $130 million in Senior Non-Convertible Preferred and more than $50 million of Series C Preferred equity in an oversubscribed round led by funds managed by Oaktree Capital Management, L.P. (“Oaktree”).
UserTesting Announces Pricing Of Initial Public Offering
UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, experience testing platform, today announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $14.00 per share.
Prove Launches Game-Changing Onboarding Solution with KYC Included at No Additional Cost
Prove, the modern way for businesses to enable their customers to prove their identities with just a phone, announced today that its Prove Pre-Fill™ and other onboarding solutions now include Know Your Customer (KYC) and anti-money laundering (AML) checks, including sanctions, watchlists, and politically exposed persons (PEP) screening at no additional cost.
Bespoke Post Raises $40 Million Series B To Help You Discover Small Brands
Bespoke Post, a multi-category e-commerce retailer, announces a $40 million Series B funding round led by NewSpring to fuel the rapid growth of the business and hone in on their efforts to help customers discover the most unique small brands.
23andMe Agrees to Acquire Lemonaid Health
23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced the signing of a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online.
UserTesting Files Registration Statement for Proposed Initial Public Offering
UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, enterprise SaaS platform, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock.
Why Security And Digital Trust Are The Key To Open Banking’s Success
In July, the White House issued an executive order asking the CFPB to work on rules for secure data sharing between consumers and banks. The order intends to promote healthy competition in financial services, enabling consumers with better choices and improving security in financial data exchange.